Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Sudeshna Dhar, Sandeepa Shetty, Mani Bharathi T.I., Anne Roshan Joseph, Gowri Shankar Krishnan, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Rahul Nahar, Lakshmikanth Gandikota, Anil Kamat

Blood (2023) 142 (Supplement 1): 6862.

https://doi.org/10.1182/blood-2023-181585

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6881.

https://doi.org/10.1182/blood-2023-184521

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6876.

https://doi.org/10.1182/blood-2023-179709

Published: 2023

Journal Articles

Self-Enforcing Feedback Activation Between BCL6 and Tonic Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 284.

https://doi.org/10.1182/blood.V124.21.284.284

Published: 2014

Journal Articles

Targeting Pre-B Cell Receptor and BCL6 In TCF3-PBX1 B-Lineage Acute Lymphoblastic Leukemia

Huimin Geng, PhD, Christian Hurtz, PhD, Zhengshan Chen, MD, PhD, Wei-Yi Chen, PhD, Erica Ballabio, PhD, Gang Xiao, PhD, Soo-mi Kweon, PhD, Rahul Nahar, PhD, Seyedmehdi Sojaee, PhD, Lai N. Chan, PhD, Behzad Kharabi Masouleh, MD, David B. Sykes, MD, PhD, Ari Melnick, MD, Robert Roeder, PhD, Thomas Milne, PhD, Markus Muschen, MD

Blood (2013) 122 (21): 349.

https://doi.org/10.1182/blood.V122.21.349.349

Published: 2013

Journal Articles

Integrative Analysis of Ikaros-Dependent Changes of Transcriptional Regulation and Tyrosine Phosphorylation Events in Ph + ALL

Huimin Geng, PhD, Rahul Nahar, PhD, Parham Ramezani-Rad, Zhengshan Chen, MD, PhD, Jeffrey W. Tyner, PhD, Bill H. Chang, MD, PhD, Bjorn Titz, PhD, Maike Buchner, PhD, Christian Hurtz, Thomas G. Graeber, PhD, Brian J. Druker, Elisabeth Paietta, PhD, Ari Melnick, MD, Cheryl L. Willman, MD, William L. Carroll, MD, Markus Muschen, MD

Blood (2012) 120 (21): 528.

https://doi.org/10.1182/blood.V120.21.528.528

Published: 2012

Journal Articles

Mechanisms of Ikaros-Mediated Tumor Suppression

Rahul Nahar, Parham Ramezani-Rad, Sinisa Dovat, MD, PhD, Maike Buchner, Thomas G Graeber, PhD, Markus Muschen

Blood (2011) 118 (21): 408.

https://doi.org/10.1182/blood.V118.21.408.408

Published: 2011

Journal Articles

Pre-B Cell Receptor-Mediated Activation of BCL6 Induces Pre-B Cell Quiescence Through Transcriptional Repression of MYC

Rahul Nahar, Parham Ramezani-Rad, Maximilian Mossner, Cihangir Duy, Leandro Cerchietti, MD, Huimin Geng, PhD, Hassan Jumaa, PhD, B. Hilda Ye, PhD, Ari Melnick, MD, Markus Muschen

Blood (2011) 118 (21): 1406.

https://doi.org/10.1182/blood.V118.21.1406.1406

Published: 2011

Journal Articles

Pre-B cell receptor–mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC

Rahul Nahar, Parham Ramezani-Rad, Maximilian Mossner, Cihangir Duy, Leandro Cerchietti, Huimin Geng, Sinisa Dovat, Hassan Jumaa, B. Hilda Ye, Ari Melnick, Markus Müschen

Blood (2011) 118 (15): 4174–4178.

https://doi.org/10.1182/blood-2011-01-331181

Published: 2011

Includes: Supplemental data

Journal Articles

SYK Is a Tumor Suppressor In Pre-B Cell Acute Lymphoblastic Leukemia and Not a Therapeutic Target

Carina Ng, Rahul Nahar, Emily Elliott, Clifford A. Lowell, Markus Muschen

Blood (2010) 116 (21): 4199.

https://doi.org/10.1182/blood.V116.21.4199.4199

Published: 2010

Journal Articles

IKAROS and BCL6 Limit Pre-B Cell Expansion and Prevent Leukemogenesis Downstream of the Pre-B Cell Receptor

Rahul Nahar, Parham Ramezani-Rad, Cihangir Duy, Sinisa Dovat, B. Hilda Ye, PhD, Ari M. Melnick, Markus Muschen

Blood (2010) 116 (21): 146.

https://doi.org/10.1182/blood.V116.21.146.146

Published: 2010

Journal Articles

Mechanisms of Pre-B Cell Receptor-Inactivation In Acute Lymphoblastic Leukemia

Cihangir Duy, Daniel Nowak, MD, Lars Klemm, Rahul Nahar, Carina Ng, Emily Elliott, Wolf-Karsten Hofmann, Nora Heisterkamp, Clifford A. Lowell, Phillip Koeffler, Markus Muschen

Blood (2010) 116 (21): 147.

https://doi.org/10.1182/blood.V116.21.147.147

Published: 2010

Journal Articles

Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes

Gabriela B. Iwanski, MD, Nils H. Thoennissen, MD, Joy Nakitandwe, BSc, MSc, PhD, Patricia Lin, Norihiko Kawamata, Rahul Nahar, Parham Ramezani-Rad, Shann-Ching Chen, Sheila Shurtleff, PhD, Daniel Nowak, MD, Christian Ruckert, Martin Dugas, MD, Carsten Bokemeyer, MD, Grazia Fazio, Andrea Biondi, Professor, MD, Giovanni Cazzaniga, PhD, James R. Downing, MD, Markus Müschen, H. Phillip Koeffler, MD

Blood (2010) 116 (21): 3231.

https://doi.org/10.1182/blood.V116.21.3231.3231

Published: 2010

Journal Articles

Pre-B Cell Receptor Signaling Distinguishes E2A-PBX1 From Other Subtypes of Acute Lymphoblastic Leukemia

Rahul Nahar, Daniel Trageser, Lars Klemm, Cihangir Duy, Wolf-Karsten Hofmann, Eugene Park, Yong-mi Kim, Nora Heisterkamp, Hassan Jumaa, Markus Muschen

Blood (2010) 116 (21): 274.

https://doi.org/10.1182/blood.V116.21.274.274

Published: 2010

Journal Articles

BCL6-Mediated Survival Signaling Promotes Drug-Resistance in BCRABL1- Driven Acute Lymphoblastic Leukemia

Cihangir Duy, J. Jessica Yu, Leandro Cerchietti, Lars Klemm, Rahul Nahar, Yong-mi Kim, Nora Heisterkamp, Giovanni Martinelli, Wolf-Karsten Hofmann, MD, Hassan Jumaa, Ari Melnick, B. Hilda Ye, PhD, Markus Muschen

Blood (2008) 112 (11): 295.

https://doi.org/10.1182/blood.V112.11.295.295

Published: 2008

Journal Articles

Aberrant Splicing of the SLP65 SH2 Domain Enables Pre-B Cell Transformation and Compromises the Leukemia-Suppressive Function of the Pre-B Cell Receptor

Cihangir Duy, Lars Klemm, Rahul Nahar, Peter van Essen, Mieke Sprangers, Yong-mi Kim, Eugene Park, Giovanni Martinelli, Nora Heisterkamp, Wolf-Karsten Hofmann, MD, Hassan Jumaa, Markus Muschen

Blood (2008) 112 (11): 294.

https://doi.org/10.1182/blood.V112.11.294.294

Published: 2008

Journal Articles

Pre-B Cell Receptor Signaling Prevents Leukemic Transformation by BCR-ABL1

Daniel Trageser, Cihangir Duy, Lars Klemm, Tanja Gruber, Rahul Nahar, Eugene Park, Yong-mi Kim, John Groffen, Nora Heisterkamp, Wolf-Karsten Hofmann, MD, Giovanni Martinelli, Richard T Williams, MD, PhD, Hassan Jumaa, Markus Muschen

Blood (2008) 112 (11): 15.

https://doi.org/10.1182/blood.V112.11.15.15

Published: 2008

Journal Articles

The Pre-B Cell Receptor Suppresses Leukemogenesis by Censoring MYC Expression.

Rahul Nahar, Daniel Trageser, Lars Klemm, Cihangir Duy, Peter van Essen, Yong-mi Kim, Nora Heisterkamp, Giovanni Martinelli, Wolf-Karsten Hofmann, MD, Hans-Martin Jack, Hassan Jumaa, Markus Muschen

Blood (2008) 112 (11): 1918.

https://doi.org/10.1182/blood.V112.11.1918.1918

Published: 2008

NARROW

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Self-Enforcing Feedback Activation Between BCL6 and Tonic Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia

Targeting Pre-B Cell Receptor and BCL6 In TCF3-PBX1 B-Lineage Acute Lymphoblastic Leukemia

Integrative Analysis of Ikaros-Dependent Changes of Transcriptional Regulation and Tyrosine Phosphorylation Events in Ph + ALL

Mechanisms of Ikaros-Mediated Tumor Suppression

Pre-B Cell Receptor-Mediated Activation of BCL6 Induces Pre-B Cell Quiescence Through Transcriptional Repression of MYC

Pre-B cell receptor–mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC

SYK Is a Tumor Suppressor In Pre-B Cell Acute Lymphoblastic Leukemia and Not a Therapeutic Target

IKAROS and BCL6 Limit Pre-B Cell Expansion and Prevent Leukemogenesis Downstream of the Pre-B Cell Receptor

Mechanisms of Pre-B Cell Receptor-Inactivation In Acute Lymphoblastic Leukemia

Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes

Pre-B Cell Receptor Signaling Distinguishes E2A-PBX1 From Other Subtypes of Acute Lymphoblastic Leukemia

BCL6-Mediated Survival Signaling Promotes Drug-Resistance in BCRABL1- Driven Acute Lymphoblastic Leukemia

Aberrant Splicing of the SLP65 SH2 Domain Enables Pre-B Cell Transformation and Compromises the Leukemia-Suppressive Function of the Pre-B Cell Receptor

Pre-B Cell Receptor Signaling Prevents Leukemic Transformation by BCR-ABL1

The Pre-B Cell Receptor Suppresses Leukemogenesis by Censoring MYC Expression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only